A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis
NCT ID: NCT00002169
Last Updated: 2005-06-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
TREATMENT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nelfinavir mesylate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* HIV infection.
* Newly diagnosed or first progression of CMV retinitis.
Exclusion Criteria
Excluded:
Prior therapy (or less than 2 weeks) with protease inhibitor other than saquinavir.
13 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Agouron Pharmaceuticals
INDUSTRY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Univ of Southern California / LA County USC Med Cntr
Los Angeles, California, United States
Univ of California / UCI Med Ctr
Orange, California, United States
Univ of California / San Diego Treatment Ctr
San Diego, California, United States
Harbor UCLA Med Ctr
Torrance, California, United States
George Washington Univ
Washington D.C., District of Columbia, United States
Northwestern Univ / SOCA
Chicago, Illinois, United States
Univ of Texas Med Branch
Galveston, Texas, United States
Baylor Univ
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Study 517
Identifier Type: -
Identifier Source: secondary_id
AG1343-517
Identifier Type: -
Identifier Source: secondary_id
259A
Identifier Type: -
Identifier Source: org_study_id